“Computer-Assisted Design of benzoisoxazol derivatives inhibitors of Bromodomain-containing protein 4 (BRD4) with Favorable Pharmacokinetic Profile”, Int. J. Pharm. Sci. Drug Res., vol. 15, no. 5, pp. 647–664, Sep. 2023, doi: 10.25004/IJPSDR.2023.150514.